Direct oral anticoagulants such as apixaban, edoxaban, and rivaroxaban are typically characterized by what property compared with warfarin?

• A. Direct oral anticoagulants generally have shorter half-lives than warfarin
• B. Direct oral anticoagulants have longer half-lives than warfarin
• C. Direct oral anticoagulants have the same half-lives as warfarin
• D. Direct oral anticoagulants have no half-life

Answer: (A)

The key idea is how long these drugs stay active in the body. Direct oral anticoagulants like apixaban, edoxaban, and rivaroxaban have shorter half-lives than warfarin, so their anticoagulant effects wear off more quickly after you stop taking them. Warfarin has a long half-life—roughly 36 to 42 hours on average—while DOACs are typically around 9 to 14 hours. That difference means DOACs can be stopped a day or so before a procedure and their effects lessen faster if you miss a dose, whereas warfarin’s effect lingers longer. So the best way to describe them is that they generally have shorter half-lives than warfarin. The other ideas—longer half-lives, the same half-life, or no half-life—don’t fit how these drugs behave pharmacokinetically.